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This study was performed to review studies carried out in Korea reporting toxic re-
actions to traditional Chinese medicines (TCMs) as a result of heavy metal contam-
ination. PubMed (1966--August 2013) and International Pharmaceutical Abstracts 
(1965--August 2013) were searched using the medical subject heading terms of 
“Medicine, Chinese Traditional,” “Medicine, Korean Traditional,” “Medicine, Tra-
ditional,” “Metals, Heavy,” and “Drug Contamination”. For Korean literature, Ko-
rea Med (http://www.koreamed.org), the Korean Medical Database (http://kmbase.
medric.or.kr), National Discovery for Science Leaders (www.ndsl.kr), Research In-
formation Sharing Service (http://www.riss.kr), and Google Scholar were searched 
using the terms “Chinese medicine,” “Korean medicine,” “herbal medicine,” and 
“metallic contamination” in Korean. Bibliographies of case reports and case series, 
identified using secondary resources, were also utilized. Only literature describing 
cases or studies performed in Korea were included. Case reports identified clear is-
sues with heavy metal, particularly lead, contamination of TCMs utilized in Korea. 
No international standardization guidelines for processing, manufacturing and mar-
keting of herbal products exist. Unacceptably high levels of toxic metals can be 
present in TCM preparations. Health care providers and patients should be educated 
on the potential risks associated with TCMs. International advocacy for stricter 
standardization procedures for production of TCMs is warranted. 
Key Words:   Medicine, Korean traditional, medicine, chinese traditional, metals, 
heavy
INTRODUCTION
The terms “oriental medicine,” “eastern medicine,” or “traditional Chinese medi-
cine” (TCM) refer to a comprehensive medical practice developed in Asian coun-
tries. This practice, which can be traced back 3000 years, employs a philosophical 
and holistic approach to treating humans, based on the yin-yang, the five elements 
(wood, fire, earth, metal, and water), and employing massage, acupuncture, clini-
cal diagnosis, and herbology.1,2 TCM makes use of both crude Chinese prepara-
tions of plant matter, animal parts, or minerals and manufactured Chinese proprie-
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contamination” in Korean. Bibliographies of case reports 
and case series, identified using secondary resources, were 
also utilized. We only included literature describing adverse 
events in humans associated with metal contamination of 
TCM and studies performed in Korea.
RESULTS
 
In total, 10 publications were retrieved and included in this 
review. The publications identified are described in more 
detail below. 
In one study investigating 45 cases of lead poisoning in 
Korea from 1973 to 2002, TCM was the most frequent cause 
of non-occupational lead poisoning.9 In this study, the aver-
age duration of TCM intake was 7.3±3.8 months (ranging 
from 3 days to 4 years). When TCMs were analyzed for lead 
content, the average daily lead intake from TCMs was found 
to be in the range of 5 mg to 3 g. According to the Joint Food 
and Agriculture Organization and WHO Expert Committee 
on Food Additives in 1986, the Provisional Tolerable Weekly 
Intake for lead from all sources is 25 mcg per kilogram of 
body weight.9 Therefore, lead intake from TCM in this study 
was 3--4000 times higher than the recommended amount. 
Most patients (82.2%) in this study complained of abdominal 
pain as a result of lead intoxication in TCMs. Other symp-
toms included headache, vomiting, and constipation. The 
most frequent laboratory finding was mild anemia. Elevated 
reticulocyte count and bilirubin, aspartate aminotransferase, 
and alanine transaminase levels were also observed. Levels 
of 24-h urinary lead were available in 31 patients, and the 
mean value was 547.0±183.8 mcg/L (normal, <150 mcg/L). 
Levels of 24-h urinary δ-aminolevulinic acid (ALA) were 
available in 22 patients, and the mean value was 44.2±10.9 
mg/L (normal, <19 mg/L). ALA is involved in porphyrin 
synthesis, and 24-h urinary δ-ALA level is generally elevat-
ed in patients with lead poisoning.10
A total of 9 Korean case reports or case series (including 
descriptions of 22 cases in total) of metal poisoning by 
TCM were identified. These are listed in chronological or-
der in Table 1. Twenty patients had lead poisoning, one had 
arsenic poisoning, and one had cadmium poisoning. All pa-
tients with lead poisoning were admitted to a hospital be-
cause of complaints of abdominal pain and gastrointestinal 
(GI) symptoms. Laboratory results indicated anemia with 
basophilic stippling of red blood cells (RBCs), which is most 
commonly associated with lead poisoning. Metal levels in 
tary medicines (CPMs), defined as “a medicinal product 
used for a therapeutic purpose”.3
Globally, Eastern medicine has become a popular alterna-
tive therapy for preventing or curing disease. The World 
Health Organization (WHO) has reported its use by 50--90% 
of the population in some Asian countries in 2008.4 This has 
led to a significant increase in annual expenditure on tradi-
tional herbal medicine in some Asian countries. In Korea, 
annual expenditure on traditional medicine increased from 
US$ 4.4 billion in 2004 to US$ 7.4 billion in 2009.4
The high prevalence of Eastern medicine use has led to 
safety concerns, especially in relation to herbal medicines. 
These include poor quality control and adulteration of herb-
al preparations, which can expose patients to unexpected 
risk. TCM may contain toxic contaminants such as heavy 
metals, pesticides or other harmful materials that become 
part of the pharmaceutical preparation during the process of 
growing, collecting, and manufacturing. Contamination of 
soil, water, and air directly leads to contamination of plants 
and herbal preparations, and high levels of heavy metals 
such as lead, mercury, and arsenic, which have been ob-
served in some TCM and Indian herbal medicine prepara-
tions.3,5-7
This article reviews studies carried out in Korea in which 
adverse events due to metal contamination of TCMs were re-
ported. Because Koreans consume large amounts of TCMs, 
with an estimated 86% having consumed some form of 
TCM according to a National survey in 2008,4,8 this has led 
to numerous safety concerns. This review aims to provide 
metal contamination risks in TCMs used in Korea and to 
offer a perspective on regulation of these products, both in 
Korea and in the United States of America (USA).
LITERATURE REVIEW METHODS
　　　
PubMed (1966--July 2013) and International Pharmaceuti-
cal Abstracts (1965--July 2013) were searched using the 
medical subject heading terms “Medicine, Chinese Tradi-
tional,” “Medicine, Korean Traditional,” “Medicine, Tradi-
tional”, “Metals, Heavy,” and “Drug Contamination” For 
Korean literature, Korea Med (http://www.koreamed.org), 
the Korean Medical Database (http://kmbase.medric.or.kr), 
National Discovery for Science Leaders (www.ndsl. kr), Re-
search Information Sharing Service (http://www.riss.kr), and 
Google Scholar were used to search the terms “Chinese med-
icine,” “Korean medicine,” “herbal medicine,” and “metallic 
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enced severe epigastric and abdominal pain with vomiting 
for 3 weeks (child 1) and for 1 week (child 2). Blood smears 
revealed normocytic, normochromic anemia, and basophil-
ic stippling. Blood lead levels were elevated to 73 mcg/dL 
in both patients. Furthermore, urinary zinc protoporphyrin 
(ZPP) and δ-ALA levels were elevated in both cases. ZPP 
levels are directly associated with blood lead concentrations 
and have been used both as a screening and diagnostic test 
for lead poisoning.10 When the amount of lead in the chil-
dren’s TCM was assayed, the lead concentration was found 
to be 2612 mcg/g. This is a very high amount, as the toler-
ance limit for lead in such preparations is 30 mcg/g. 
Oh, et al.16 reported a case of a 53-year-old woman ad-
mitted to the hospital complaining of abdominal pain, diz-
ziness, and numbness of her hands and feet. She had taken 
unidentified TCM for 1 year to treat arthritis. Laboratory 
examinations showed normocytic hypochromic anemia 
with basophilic stippling of RBC. Blood and urinary lead 
levels were elevated to 80 mcg/dL and 541 mcg/dL, respec-
tively. Urinary ZPP was also elevated. Analysis of the pills 
involved revealed that they contained 30 mg/g lead, even 
though regulations in Korea do not allow more than 5 mg/kg 
lead in herbal medicines. 
Park, et al.17 reported a case of a 34-year-old woman with 
sideroblastic anemia. The patient was admitted to a hospital 
with abdominal pain and headache. She was found to have 
been taking unidentified TCM pills for 1 month. A periph-
eral blood smear showed polychromasia and RBCs with 
basophilic stippling. Bone marrow biopsy showed ring sid-
eroblasts. The patient’s blood lead level was elevated to 63 
mcg/dL. Urinary δ-ALA and lead levels were also elevated 
to 30.49 mg/L (normal, 0.4--3.3 mg/L) and 578.2 g/L, re-
spectively. The lead content of the herbal pills was 40063 
ppm, 8000 times higher than that permitted by regulations 
in Korea (<5 ppm).17
There were 2 cases of poisoning with metals other than 
lead, namely arsenic and cadmium. In the case involving 
arsenic, a 72-year-old man was admitted to a hospital with 
a painful, erosive patch on his penis and a violaceous pap-
ule on his scalp.18 The patient had a medical history of pros-
tate cancer for which he had received chemotherapy and ra-
diotherapy 3 years prior to this admission, but he did not 
have any scars or abnormal signs on his penis or scalp at the 
time of his cancer treatment. Other skin regions appeared 
normal. The patient had been taking unidentified TCM for 
20 years. Analysis of these pills revealed 31.4 mg of arse-
nic/kg, although Korean regulations do not allow more than 
blood and urine were measured, or 24-h urinary δ-ALA 
levels in cases of lead intoxication, identifying levels that 
were higher than the reference range. 
Kim, et al.11 reported 5 cases of lead poisoning due to in-
gestion of unidentified TCM. In these cases, the patients 
had taken pills to relieve epigastric pain (3 cases), joint pain 
(1 case), and vitiligo (1 case). All patients presented with 
abdominal pain, vomiting, and constipation. Their peripher-
al blood test results showed mild anemia, reticulocytosis, 
and basophilic stippling. In one medicine, lead was present 
at a level of 15% by weight. Furthermore, all patients had 
elevated blood and urinary lead levels, with elevation of 
δ-ALA and coproporphyrin (CPP) in 24-h urine. Porphy-
rins such as CPP, uroporphyrin (UPP), and protoporphyrin 
are a group of compounds involved in hemoglobin forma-
tion that are usually elevated in lead poisoning.10
Baek, et al.12 reported 6 cases of lead poisoning after in-
gestion of TCM. In these cases, the patients had received 
the medicines for general health care or analgesia. All 6 pa-
tients complained of abdominal pain and constipation. Their 
laboratory and bone marrow examinations revealed anemia 
with basophilic stippling, binucleated RBC, erythroid hy-
perplasia, and ringed sideroblasts. Lead was detected at a 
level of 9.2--256 mg per pill, and the average estimated 
amount of lead ingested through TCM was 285 mg/day 
(range, 42--725 mg/day). Elevated lead levels were ob-
served in blood and urine. Additionally, urinary CPP, UPP, 
and 24-h urine δ-ALA were elevated, reflecting lead intoxi-
cation. 
Kim, et al.13 also reported 4 cases of lead poisoning caused 
by TCM. All patients complained of acute colicky abdominal 
pain and exhibited anemia with basophilic stippling of RBC. 
Serum lead levels were elevated and ranged from 25--51 mcg/
dL (normal, <20 mcg/dL). Urinary lead levels were also ele-
vated and ranged from 31--69 mcg/dL (normal, <4 mcg/dL). 
Kim, et al.14 reported a case of a 23-year-old woman ad-
mitted to a hospital with complaints of abdominal pain and 
constipation. This patient reported taking unknown TCM 
pills for 15 days to treat eczema. Laboratory examinations 
showed normocytic, hypochromic anemia with basophilic 
stippling. Blood lead levels were elevated to 69 mcg/dL, and 
the herbal pills contained 3.32% lead, indicating that the pa-
tient had ingested a cumulative lead dose of over 3.2 g. 
Choi, et al.15 reported 2 cases of pediatric lead poisoning. 
Two children aged 11 and 13 years took unidentified TCM 
for weight loss. They took 30 pills a day for one month, 
which resulted in 13 kg of weight loss. The children experi-
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tration. Patients were treated with supportive care and most 
symptoms disappeared upon discontinuation of TCM. How-
ever, one individual with TCM-associated arsenic intoxica-
tion developed squamous cell carcinoma in his penis and 
basal cell carcinoma in his scalp, which required surgery.  
Consistent with Korean literature, studies published in 
other countries have also identified lead as a major contami-
nant of TCMs.3,4,24-26 One review of reports of excessive tox-
ic heavy metals in CPM in Singapore over 8 years found 42 
out of 2080 CPM contained mercury, arsenic, lead, and cop-
per in excessive amounts of the legal limits.3 Mercury is the 
most commonly detected excessive heavy metal, represent-
ing 66.7% of the 42 CPMs. Lead (19%), arsenic (16.7%), 
and copper (2.4%) were also detected as excessive heavy 
metals. Garvey, et al.24 acquired a random sample of tradi-
tional Asian medicines from China, Vietnam, and the USA 
and evaluated the products for lead, arsenic, and mercury 
content. In total, 54 products were acquired and prepared 
for analysis. A 0.5 g sample of each product was analyzed 
and the resulting heavy metal concentrations were mathe-
matically projected to calculate the daily dose. These results 
indicated that 49% to 75% of the TCMs contained heavy 
metals. Lead was the most commonly identified heavy metal 
in the sample collected, as 60% of the tested products deliv-
ered a daily dose of 300 mg. Moreover, 15% of the sampled 
products were found to contain toxic doses of multiple heavy 
metals. In a study conducted by the California Department 
of Health Services to screen 2609 samples of 260 imported 
CPMs, 17 products contained undeclared pharmaceuticals 
and 34 contained at least 10 ppm lead.5
Although these articles present clear evidence that pro-
cessed herbs, including CPM products, are at risk for heavy 
metal contamination, very little is known about the risk of 
such contamination in raw, and unprocessed Chinese herbs. 
Harris, et al.27 collaborated with Chinese investigators to 
conduct federally funded research to analyze heavy metals 
and pesticides in commonly prescribed raw herbs from a 
wide range of geographical areas in China. In this study, 
334 samples of raw herbs (representing 126 individual spe-
cies) were collected and examined in duplicate for arsenic, 
cadmium, chromium, lead, and mercury. Additionally, 294 
samples (representing 112 species) were tested for pesti-
cides, including the organophosphate insecticide, chlorpyri-
fos. Investigators found that 100% of these samples con-
tained at least one reference metal and 34% of the samples 
contained all the metals tested. Furthermore, 42 different 
pesticides, half of which are not registered chemicals in the 
3 mg/kg arsenic in herbal medicines. An excisional biopsy 
specimen from the patient’s penis showed squamous cell 
carcinoma in situ. Biopsy of his occipital scalp showed bas-
al cell carcinoma. 
Lee, et al.19 reported a case of a 31-year-old woman with 
cadmium-induced acute renal failure. The patient had been 
taking TCM for 5 days before developing general weak-
ness and muscle pain. Laboratory results revealed hypo-
phosphatemia, hypouricemia, hypokalemia, and metabolic 
acidosis with an increased anion gap. Serum creatinine lev-
el increased from 1.2 to 3.2 mg/dL over 8 months. Renal 
ultrasonography showed enlarged kidneys with a highly 
echogenic cortex and prominent medullary pyramids. Re-
nal biopsy showed severe tubular degeneration, confirming 
a diagnosis of Fanconi syndrome. The patient’s urinary 
cadmium concentration was 58 mcg/g, 29 times higher than 
the normal reference range. The authors concluded that an 
herbal medication containing cadmium could have caused 
this renal damage. 
Management of lead poisoning related to TCM includes 
discontinuation of the medicine and supportive care based 
on the patient’s symptoms. Chelation therapy can be used 
to eliminate some specific metals. Dimercaprol (also known 
as British anti-Lewisite), calcium disodium edetate (CaNa2 
EDTA), and oral chelators such as d-penicillamine and suc-
cimer can be used in cases of lead or arsenic poisoning. 
However, there is no evidence for beneficial effects of che-
lating therapy in cases of cadmium poisoning.20-22  
DISCUSSION
The present study identified reports of Korean individuals 
with serious symptoms of heavy metal toxicity following 
TCM usage. A total of 9 case reports with 22 cases in total 
could be directly attributed to the medications ingested, 
since analyses showed unacceptably high levels of heavy 
metal in these products. GI symptoms such as abdominal 
pain, anorexia, nausea, constipation, and anemia with baso-
philic stippling are common signs and symptoms of lead in-
toxication, and were also present in patients using TCMs in 
this review. Because these signs and symptoms of metal 
contamination associated with TCMs were non-specific,22,23 
assessment was delayed and sometimes involved unneces-
sary testing, such as bone marrow biopsies, as shown in this 
review. This finding indicated the importance of obtaining a 
careful medical history of patients, including TCM adminis-
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pesticides in individual herbal medicines. Because of these 
strict regulations on quality control of TCMs, the frequency 
of adverse events from contamination in TCMs has been re-
duced. However, as seen in this review, adverse events aris-
ing from contaminated TCMs have been reported recently, 
emphasizing the importance of continuous and careful moni-
toring of TCM safety. Like the MedWatch program in the 
USA, the KFDA disseminates information regarding TCM 
recalls or withdrawals, both in Korea and in other countries 
via its website (http://www.kfda.go.kr).28 Over the last 5 years 
from 2007 to 2011, 631 TCMs have been banned from the 
Korean market because of safety concerns. The absence of a 
labeled active ingredient (i.e., misbranding) led to withdraw-
al of 103 (16.3%) of these TCMs. Furthermore, contamina-
tion with sulfur dioxide (SO2), heavy metals, pesticides, or 
biological growth (such as fungi or bacteria) led to the with-
drawal of 282 (44.7%) of the TCMs. Fifty-five percent 
(n=154) were contaminated with SO2, 32.4% (n=66) with 
cadmium, and 7.4% (n=21) with lead, which may have the 
possibility of causing adverse events of TCM in future. 
Guidelines issued in the USA by the FDA Office of Com-
pliance (updated in 2010) offer recommendations regarding 
the marketing and sale of homeopathic drugs, a category 
which includes TCMs.29 The FDA stated that drugs or prep-
arations recognized in the Homeopathic Pharmacopeia of 
the United States (HPUS) would be subject to regulation in 
accordance with the Dietary Supplement Health and Edu-
cation Act of 1994, which ensures that Current Good Manu-
facturing Practices and United States Pharmacopeia (USP) 
standards are followed.29 The USP, based upon FDA, Cana-
dian and European Medicines Agency standards, has fur-
ther proposed the limitation of the permissible daily expo-
sure to heavy metals from all ingestible sources to be 10 
mcg/day, 2 mcg/day or 15 mcg/day for each 50 kg of body 
weight for lead, methyl mercury, and arsenic, respectively.30 
The HPUS contains approximately 1300 drugs and all in-
gredients plus manufacturing standards for all recognized 
drugs and dosage forms.31 The FDA is prompt to issue con-
sumer and practitioner guidance through the MedWatch sys-
tem regarding any problems with prescription or non-pre-
scription drug supply, including contaminated products from 
overseas. Unfortunately, illegal and unregistered products 
could potentially penetrate US borders from foreign nations.
Unacceptably high levels of toxic metals or pesticides can 
be present in TCM preparations. Addressing these issues by 
using standardized processes and product validation by an 
appropriate third-party agency may optimize patient safety 
US, were detected in 108 of the 294 samples (36.7%). The 
number of pesticide contaminants identified per sample 
ranged from 1 to 9. If these preparations were ingested 
chronically, 231 samples (69.2%) with heavy metals and 81 
samples (28%) with pesticides could contribute to elevated 
levels of exposure. Herbs may become adulterated with 
pesticides via growth in contaminated soils, storage in con-
taminated containers, or irrigation with contaminated wa-
ter.5 Wild plants harvested for this study (representing 
37.1% of the samples) had higher contaminant concentra-
tions than cultivated (farmed) plants. Furthermore, geo-
graphical variations in the natural mineral content of the 
plant sources did not contribute to variations in heavy metal 
or pesticide concentrations in the samples (r2 <0.1). 
Koreans widely consider TCM treatments to be harmless 
since they are of a natural origin and have been used histor-
ically without any serious adverse effects. Some patients 
also view them as nutritional supplements, which they are 
willing to take for several months, regardless of their dis-
ease state, believing they can improve energy or boost im-
munity. Patients believe that any adverse effects of TCM 
are because of a mismatch between one’s body type and the 
herbal material used, instead of a direct result of herbal 
preparation ingestion. For this reason, harmful effects of 
TCMs are often under-recognized and under-reported. The 
present study identified reports of serious heavy metal tox-
icity in only a very low percentage of the large number of 
people regularly taking TCMs in Korea. However, consid-
ering the under-detection and under-reporting of adverse 
TCM effects, along with the frequency of TCM contamina-
tion identified in the studies described above, the preva-
lence of heavy metal toxicity may be greater than what is 
reflected in these 9 identified Korean studies. In the absence 
of adequate product quality, purity, or standardization assur-
ances prior to marketing TCM, there is no guarantee of 
safety or efficacy. 
Recognition of the potential dangers of TCMs has led to 
the establishment of supervision and regulation of quality 
control by the Korean government, enforced by the Korean 
Food and Drug Administration (KFDA). Korean regula-
tions issued in 1995 stated that the total heavy metal con-
tent of medicinal plants should not exceed 30 ppm.28 This 
guidance was modified in 2008 to account for the toxicity 
of individual heavy metals. For example, TCMs should not 
contain more than 5 mg/kg lead, 3 mg/kg arsenic, 0.2 mg/kg 
mercury, or 0.3 mg/kg cadmium. Also, The Korean Herbal 
Pharmacopoeia specifies each limit for heavy metals and 
Metal Contamination of Chinese Medicines in Korea
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tivation and harvest to the finished product, in concert with 
an increased emphasis on producing a global alliance for 
quality assurance and surveillance of contaminants in prod-
ucts containing herbal and other natural materials.
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and improve clinical outcomes for patients seeking treat-
ment with herbal medicines. Other regulatory approaches 
have been proposed by Genuis, et al.,32 who conclude that 
regulatory oversight would be heavily contested by the TCM 
and nutraceutical industries. Rather, a system of self-regula-
tion with adjunctive governmental regulatory oversight could 
be more effective to meet the goal of providing safe and ef-
fective products for public consumption. Transparent report-
ing of ingredient origin, country of manufacture, as well as 
contaminant test results would provide an environment of 
transparency that would allow both practitioners and pa-
tients to select the most appropriate therapies.32 Internal 
controls including batch-to-batch comparisons for consis-
tency and purity as well as a system of accreditation for 
sources of botanical- or animal-based ingredients are just a 
few of several ideas to promote increased product quality. In 
this spirit, urgent engagement from governments and regula-
tory authorities to ensure that TCMs and other natural prod-
ucts are correctly labeled and are free from harmful con-
taminants is warranted. If jurisdiction of authority becomes 
problematic for some regulatory bodies, importation of fin-
ished products from foreign sources could be banned while 
still allowing for regulated importation of raw ingredients 
(if domestic cultivation cannot occur) with final production 
to be conducted domestically.
LIMITATION
The Korean reports of heavy metal contamination in TCM 
identified in this study were case reports, not randomized 
clinical trials. In this context, case reports may not account 
for chronic exposure to heavy metals due to one’s occupa-
tion, living environment or dietary intake.
CONCLUSIONS
Unacceptably high levels of toxic metals can be present in 
TCM preparations. The global TCM industry needs to ad-
dress a host of regulatory and production issues that are neg-
atively affecting patient safety. Health care providers should 
be educated on the potential risks associated with TCMs and 
patients should also be made aware of the potential safety 
concerns and encouraged to speak with their healthcare pro-
viders before starting any supplement. Further research is 
warranted to evaluate TCM and CPM production from cul-
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